Parnax Lab

Parnax Lab Enterprise Value

The Enterprise Value (EV) of Parnax Lab (506128.BO) as of Nov 18, 2026 is 2.12 B INR. In the previous year, Enterprise Value (EV) was 2.23 B INR — a change of -5.03% (lower).

Enterprise Value

2.12 BINR

YoY

-5.03%

Last updated:

Enterprise Value (EV) of Parnax Lab is 2025 2.12 B INR. Enterprise Value (EV) of Parnax Lab was 2024 2.23 B INR. It decreases by -5.03% lower compared to the previous year.

The Parnax Lab Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
1.78 B INR
Jan 1, 2019
1.84 B INR
Jan 1, 2020
1.93 B INR
Jan 1, 2021
2.00 B INR
Jan 1, 2022
2.06 B INR
Jan 1, 2023
1.96 B INR
Jan 1, 2024
2.23 B INR
Jan 1, 2025
2.12 B INR
The Parnax Lab Enterprise Value history
YEAREnterprise ValueYoY
2.12 BINR-5.03%
2.23 BINR+13.63%
1.96 BINR-4.78%
2.06 BINR+2.82%
2.00 BINR+4.00%
1.93 BINR+4.66%
1.84 BINR+3.55%
1.78 BINR-13.13%
2.05 BINR-1.07%
2.07 BINR-1.24%
2.09 BINR+6.67%
1.96 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

Enterprise Value (EV) of Parnax Lab is 2.12 B INR in 2025.

Enterprise Value (EV) of Parnax Lab changed from 2.23 B INR to 2.12 B INR, representing a -5.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s INR, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' INR varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Parnax Lab with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Parnax Lab

All Key Metrics — Parnax Lab